Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab

Br J Dermatol. 2007 Aug;157(2):417-9. doi: 10.1111/j.1365-2133.2007.08048.x. Epub 2007 Jun 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Dermatologic Agents / therapeutic use*
  • Epidermolysis Bullosa Acquisita / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Rituximab
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Dermatologic Agents
  • Immunosuppressive Agents
  • Rituximab